US Patent Issued to Novartis on July 14 for "Use of nicotinic acetylcholine receptor alpha 7 activators" (Swiss, Canadian, American Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,415, issued on July 14, was assigned to Novartis AG (Basel, Switzerland).

"Use of nicotinic acetylcholine receptor alpha 7 activators" was invented by Therese Di Paolo (Quebec, Canada), Dominik Feuerbach (Basel, Switzerland), Baltazar Gomez-Mancilla (Basel, Switzerland) and Donald Johns (Woburn, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention concerns the use of a nicotinic acetylcholine receptor alpha 7 activators for the treatment, prevention or delay of progression of dyskinesia associated with dopamine agonist therapy in Parkinson's Disease."

The patent was filed on July 16, 2021, under Application No. 17/378,136.

*For furth...